Diagnosis of inflammatory bowel disease currently requires an invasive procedure. New research identifies a way to identify the disease using a blood draw.
Category: Autoimmune Conditions
Antibody treatment delays start of Type 1 diabetes by two years
A therapy delayed the onset of Type 1 diabetes in at-risk people by about two years, new results from a clinical trial show.
Sleep science takes the stage at Big Data in Precision Health
Speakers at Stanford's Big Data in Precision Health conference discuss how their work with big data impacts and informs sleep research.
Type 1 diabetes: Developing an early warning system
Type 1 diabetes starts out as a sneak attack by bad-actor antibodies. But scientists at Stanford and UCSF have developed an early-warning system.
Rheumatoid arthritis may be triggered by a missing molecular “anchor,” but new research suggests a fix
Stanford scientists have dug up a defect at the heart of rheumatoid arthritis: a faulty "anchor" that should be tethering a key molecule to the spot inside immune cells where it has to be in order to do its job. It seems this defect can be reversed with a not yet commercially available small-molecule drug.
Patient finds relief in treatment for chronic esophagus inflammation
A Stanford medicine patient regains quality of life after receiving treatment for his rare inflammatory esophagus condition.
Patient shares experience with celiac disease: It’s a serious autoimmune condition, but “not the end of the world”
In a video, Stanford Children's Health's Healthier, Happier Lives Blog introduces a patient with celiac disease and discusses the symptoms, diagnosis and treatment of the autoimmune disorder.
Common link — a glucose-guzzling immune cell — involved in coronary artery disease and rheumatoid arthritis
Rheumatoid arthritis and coronary artery disease share a common culprit: an important type of immune cell, called a macrophage, that has gone haywire. Stanford investigators have zeroed in on a molecular defect in macrophages' metabolic process that drives both disorders.
Advanced cell-labeling technology identifies suspect cell type, possible new therapeutic approach to multiple sclerosis
Researchers have identified an immune cell type with an apparently critical role in multiple sclerosis, and a way to block its entry into the brain.
Exercise elevates blood signature difference between people with, without chronic fatigue syndrome
A new study suggests that a blood test following exercise may be a good way to differentiate between people who have ME/CFS and people who don't.
Calcium channel plays integral role in immune response
Welcome to Biomed Bites, a weekly feature that introduces readers to some of Stanford’s most innovative biomedical researchers. The immune system's main players — the B cells …
The latest on the pregnancy risks for women with lupus
Women with lupus, an autoimmune disorder that can attack a variety of tissues, were once counseled to avoid pregnancy. Now, physicians tailor their advice to …
New perspective: Potential multiple sclerosis drug is actually old (and safe and cheap)
About 400,000 people in the United States are affected by multiple sclerosis (often referred to by the acronym MS), an autoimmune disorder in which rogue …
The importance of providing patient support in the face of a life-threatening illness
We’ve partnered with Inspire, a company that builds and manages online support communities for patients and caregivers, to launch a patient-focused series here on Scope. Once …
Can a safe, cheap pill prevent type 1 diabetes?
Type 1 diabetes, an autoimmune disorder once known as juvenile diabetes because it tends to strike during adolescence or earlier, affects one in every 300 …
Women and men’s immune system genes operate differently, Stanford study shows
A new technology for studying the human body’s vast system for toggling genes on and off reveals that genes connected with the immune system switch …